Skip to main content
logo
Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
70.20
+0.30 (0.43%)
Nov 6, 2026, 1:30 PM CST

Lumosa Therapeutics Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
11,75832,76642,22411,2686,4256,117
Market Cap Growth
-65.45%-22.40%274.74%75.37%5.04%17.77%
Enterprise Value
11,13531,94541,69910,3805,2544,757
Last Close Price
70.20194.50250.0068.1539.3140.16

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----63.75
PS Ratio
342.12914.461078.41197.97241.17352.32
PB Ratio
9.4421.5721.917.893.852.89
P/TBV Ratio
9.5021.7122.098.054.012.95

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-891.551065.00182.37197.19273.96

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.010.000.010.000.01
Net Debt / Equity Ratio
-0.51-0.52-0.70-0.58-0.71-0.68
Net Debt / EBITDA Ratio
2.102.403.812.334.093.57
Net Debt / FCF Ratio
2.412.194.532.433.903.18
Asset Turnover
0.020.020.020.030.010.01
Inventory Turnover
0.160.140.210.140.130.13
Quick Ratio
5.266.286.923.985.656.60
Current Ratio
6.477.377.644.766.447.23
Return on Equity (ROE)
-26.11%-20.11%-26.03%-16.16%-26.63%5.18%
Return on Assets (ROA)
-12.15%-11.02%-11.78%-13.26%-9.03%-13.01%
Return on Capital Employed (ROCE)
-24.40%-22.00%-18.50%-26.20%-18.30%-20.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.18%-1.04%-1.01%-2.11%-7.70%1.57%
FCF Yield
-2.22%-1.10%-0.70%-3.04%-4.71%-7.40%
Buyback Yield / Dilution
-0.40%-1.68%-0.64%-0.03%-7.61%-24.92%